PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#medicalaffairsoutsourcing

Tag

Think Differently — A New Approach to Transforming Medical Affairs in Big Pharma

Think Differently — A New Approach to Transforming Medical Affairs in Big Pharma

In the fast-paced world of medical and regulatory affairs, large pharmaceutical companies are under increasing pressure to stay ahead. PharmaMedic Consultancy (PMC) understands this need and offers a flexible, expert-driven solution. With a network of over 100 consultants, PMC provides specialised, outsourced expertise that integrates seamlessly with your team to handle crucial tasks—from launch planning and KOL (Key Opinion Leader) engagement to regulatory compliance and certification.

14 Nov 2024
Read More
From Support to Strategy – How Medical Affairs Drives Smarter Drug Development

From Support to Strategy – How Medical Affairs Drives Smarter Drug Development

Medical Affairs in recent times has stepped out of the background to become a core strategic partner in pharma and biotech companies. No longer just a support team, MA is at the forefront — blending science, business, and healthcare to create a development process that is faster and deeply centred on patient needs.

11 Nov 2024
Read More
Maximise Success for Generic Manufacturers

Maximise Success for Generic Manufacturers

The global demand for generic pharmaceuticals is growing, but manufacturers face significant hurdles. Regulatory complexity, market entry barriers, and the need for product differentiation require strategic thinking. At the same time, manufacturers must maintain tight control over costs to succeed.

30 Oct 2024
Read More
Medical affairs outsourcing trends and benefits

Medical affairs outsourcing trends and benefits

What is the outlook for medical affairs up to 2030, and what are the advantages for pharma and biotechs from outsourcing this function to external specialists?

19 Dec 2022
Read More

Categories

  • Awards
  • Consultants
  • Events
  • Funding
  • News
    • Cancer
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugdevelopment #drugregulation #EC #EFPIA #EMA #EU #HorizonEurope #HTA #innovation #lifesciences #marketaccess #medicalaffairs #medicalaffairsoutsourcing #medicaldevice #medicinesaccess #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #RWE #startups #UKgovernment #ukregulation #VPAS #WindsorFramework AI Biotech COVID-19 Healthcare Medical Affairs medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2026 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital